United States one step away from approval of its first coronavirus vaccine

With a register of cases, deaths and hospitalizations for covid-19 in record levels in the United States, today a panel of experts will have a key vote pave the way for the national regulator to authorize the use of the first vaccine against coronavirus in this country, the one developed by Pfizer and BioNTech.

The advisory board of Food and drug administration (FDA) had a pre-vote meeting this morning, which is seen as the last step before the northern country begins receiving and distributing millions of doses of the vaccine among its states.

“Today we will consider making available to millions of Americans a still-under-investigating vaccine that has been developed, tested and revised in record time, with additional testing still underway in studies in progress. course, ”he said. Doran fink, deputy director of the vaccines division of the FDA.

“The American public demands and deserves a rigorous, comprehensive and independent review of the data,” he added at the start of the meeting. Advisory Commission on Vaccines and Related Biologicals, broadcast live on the Internet.

The 17 full members and 13 guests of the commission, made up of independent experts, representatives of the pharmaceutical industry and consumers, will organize a vote on whether or not to authorize the vaccine.

The commission works as a kind of scientific court which analyzes and discusses data presented by US pharmaceutical companies Pfizer and German BioNTech to determine whether the vaccine is safe and effective enough to authorize its emergency use.